3:00 PM
 | 
Feb 12, 2018
 |  BC Extra  |  Politics & Policy

BIO report shows lagging innovation for pain, addiction

The Biotechnology Innovation Organization called attention to lower venture funding and fewer clinical-stage novel compounds within pain and addiction indications in its second report in a series on funding and R&D for highly prevalent chronic diseases.

"Lower investment and pipeline breadth in pain and addiction...

Read the full 208 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >